In order to avoid disruptions in the supply of medicinal products, transitional measures for medicinal products which have been released for sale or distribution without the safety features before the date of application of this Regulation in the Member State or Member States where the product is placed on the market are necessary.
Recital 43, Regulation (EU) 2016/161
In forcesince 2 Oct 2015